Go talk to your Iranian friends, students, postdocs, colleagues. Offer to take on their tasks at work. There is little contact with Iran right now from outside - most of us have no idea what it is like not to have contact with family members while they are being attacked.
07.03.2026 20:22
π 10
π 3
π¬ 2
π 0
Happy to share our new preprint on the mechanism of human tRNA 3' CCA maturation! This project was spearheaded by Bernhard Kuhle in my group, with contributions from many others and a great collaboration with the group of Peter Rehling (UMG). See highlights below!
www.biorxiv.org/content/10.6...
05.03.2026 21:43
π 20
π 13
π¬ 1
π 0
Postdoc positions in Nuclear RNA Biology - Vacancy at Aarhus University
Vacancy at Department of Molecular Biology and Genetics - RNA Biology and Innovation, Aarhus University
Postdoc positions available in my lab in Aarhus, Denmark on 'Mammalian Nuclear RNA Production and Turnover Systems'. Please get in touch for further information or simply apply here:
mbg.au.dk/en/news-and-...
06.03.2026 07:47
π 17
π 28
π¬ 0
π 0
Sharepic for a seminar at the MPI-IE:
Green-blue gradient background. The top left shows the name of the Max Planck Institute for Immunobiology and Epigenetics and its logo. Below is the heading 'MAX PLANCK SEMINAR FREIBURG'. The center displays the lecture title: 'INSPECTING THE ROLES OF CHROMATIN ORGANIZATION IN TRANSCRIPTION REVEALED BY SPATIAL GENOMICS'. The lower left lists the date, time, and venue: 'WED, 11 MARCH 2026, 15:00', 'MPI-IE, LECTURE HALL', 'StΓΌbeweg 51, 79108 Freiburg, Germany'. The lower right shows the speaker's name and affiliation: 'Marcelo Nollmann, Center for Structural Biology, CNRS/INSERM, University of Montpellier, France'.
π€ Next week, we are happy to welcome Marcelo Nollmann from @cbsmontpellier.bsky.social | @cnrs.fr | @umontpellier.bsky.social.
His lab develops single-molecule and advanced imaging methods to investigate DNA organization, segregation and transcription in multicellular organisms.
Join us at 3pm. β¬οΈ
06.03.2026 12:05
π 8
π 6
π¬ 0
π 0
Ubiquitin & Friends Fiesta in Vienna, 29-30 April 2026.
Great speakers, small size, a friendly community, perfect for early-career researchers to connect with fellow ubiquitin enthusiasts. Sign up at www.protein-degradation.org/symposium/ and submit abstracts for talks and awards.
#ubfriends26
06.03.2026 06:48
π 17
π 14
π¬ 1
π 1
Job Details
Pls re-post: My department @oxfordbiochemistry.bsky.social are recruiting for several new faculty positions (links below). Broad search in molecular biology/biochemistry, across prokaryotes and eukaryotes. Interested in understanding life at the molecular level, this job might be for you!
1/n
05.03.2026 21:35
π 85
π 123
π¬ 2
π 3
That time of year again when I make my Mendel impression.
I suppose these are peaches and not peas, and will be furry not wrinkled, and I'm a biochemist not a geneticist, but I'm claiming it anyway.
05.03.2026 15:43
π 1
π 1
π¬ 0
π 0
Super Early Bird deadline Sunday 8 Mar! Save β¬100
Register for Machines on Genes 2026 βοΈπ§¬
Biochemical Society Harden Conference
π Heraklion, Crete | 8β11 June 2026 πβοΈ
www.eventsforce.net/biochemsoc/f...
Scientific organisers: Lori Passmore, Dana Branzei & Alessandro Costa
03.03.2026 18:36
π 5
π 5
π¬ 0
π 0
RNA 3' ends and beyond
Precisely defining transcription unit boundaries across eukaryotic genomes is fundamental to understanding individual gene function and regulation. The multifaceted process of RNA 3' end formation esβ¦
meetings.embo.org/event/26-rna3
To all 3' end (and RNA, in general) enthusiasts. I'm organising a great conference in Oxford 7th-11th Sept with @lapassmore.bsky.social and Christine Mayr. The lineup of speakers is brilliant! Registration closes 4th May. Please consider it!
05.03.2026 12:21
π 18
π 11
π¬ 0
π 0
Auf frischer Tat ertappt: Das #Influenza -Virus stiehlt die Kappe der Wirts-RNA, um sich zu vermehren. Ein Team @mpi-nat.bsky.social hat das Virus zum ersten Mal beim Diebstahl erwischt ;-) www.mpg.de/26214616/030...
05.03.2026 08:32
π 21
π 5
π¬ 0
π 0
New preprint out!
In this study, we introduce NanoFLex, a strategy that combines #HaloTag variants with #nanobodies -based immunolabeling to enable rapid, OneStep-IF #lifetime #multiplexing. Possible due to SmartSecondaries fused to #HaloTag from @nanotag.bsky.social: www.biorxiv.org/content/10.6...
04.03.2026 10:11
π 72
π 37
π¬ 1
π 3
Portrait shots of two people looking into the camera.
Two Crick group leaders are joining Cancer Grand Challenges teams to tackle big questions in cancer research.
Leanne Li leads a team studying how tumours interact with the nervous system, and Vivian Li joins a @ucl.ac.uk-led team working to rewire cancer cells.
π www.crick.ac.uk/news/2026-03...
04.03.2026 11:46
π 27
π 7
π¬ 0
π 0
SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity
Synovial sarcoma is driven by the SS18-SSX fusion oncoprotein, which has been assumed to promote tumorigenesis through its incorporation into the SWI/SNF chromatin remodeling complexes. Accordingly, therapeutic efforts have focused on targeting SS18-SSX containing SWI/SNF assemblies, yet these approaches have produced limited clinical benefit. Here, we demonstrate that SS18-SSX sustains oncogenic transcription independent of SWI/SNF activity. Despite efficient degradation and dismantling of SWI/SNF complexes, fusion occupancy at target loci and associated gene expression programs remain largely intact. Instead, we identify the acetyltransferase P300 as an essential co-factor supporting SS18-SSX chromatin binding and transcriptional activation. Targeting P300 displaces the fusion from chromatin, suppresses its transcriptional output, compromising synovial sarcoma viability. Notably, dual PROTAC mediated degradation of P300 and SWI/SNF produces strong synergistic effects, broadly disrupting SS18-SSX localization and function. These findings redefine the mechanistic basis of synovial sarcoma and reveal a mechanistically anchored therapeutic strategy for targeting its core oncogenic driver. ### Competing Interest Statement C.R.V. has been a consultant for Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer Ingelheim and Treeline Biosciences; and owns stock in Treeline Biosciences. S.A.A. has been a consultant and/or shareholder for Neomorph, Imago Biosciences, Hyku Therapeutics, C4 Therapeutics, Accent Therapeutics and Nimbus Therapeutics; and has received research support from Janssen and Syndax. N.O.C. is a co-founder, shareholder and management consultant for PhenoTherapeutics Ltd; and a shareholder in Amplia Therapeutics Ltd All other authors declare no financial interests UKRI, EP/X039633/1 Worldwide Cancer Research, https://ror.org/031tfbz57, 21-0271 Science Foundation Ireland, https://ror.org/0271asj38, 18/SIRG/5573
Synovial sarcoma is driven almost exclusively by a single oncofusion β SS18-SSX
For years, the assumptions on disease mechanisms were simple:
β‘οΈ SS18-SSX works by hijacking SWI/SNF chromatin remodeling activity
Our new study shows that assumption was wrong π§΅π
www.biorxiv.org/content/10.6...
28.01.2026 09:54
π 30
π 12
π¬ 2
π 3
Do you work on DNA or RNA protein complexes? π§¬
Come to Machines on Genes this June in Crete! βοΈ
Super early discount is ending this Sunday so register now! π
02.03.2026 22:08
π 22
π 14
π¬ 0
π 0
Predicting protein-protein interactions (PPIs) at proteome scale can take months with co-folding models due to the massive all-vs-all comparisons required.
We are excited to announce FlashPPI, a contrastive learning framework that predicts proteome wide physical interfaces in minutes. 1/π§΅
03.03.2026 15:07
π 67
π 27
π¬ 2
π 7
Exciting opportunity to work with an amazing scientist at the cutting edge of DNA repair and telomere biology.
02.03.2026 19:35
π 5
π 3
π¬ 0
π 0
π£ We are looking for new colleagues π¬π§¬π§ͺ
The @lmcb-ucl.bsky.social at University College London @ucllifesciences.bsky.social are looking for outstanding candidates to sponsor for career development fellowships. Fellows would then be assessed for tenured positions at the end of the fellowship term.
02.03.2026 17:49
π 12
π 8
π¬ 1
π 0
I am so grateful to the Blavatnik Family Foundation and the New York Academy of Sciences for this honor. Canβt wait to be back to the lab and celebrate with lab members on this special recognition of their hard work.
25.02.2026 19:58
π 81
π 11
π¬ 5
π 2
Iβm thrilled to share that my PhD work has been just published in Cell. After a long and bumpy ride, we uncovered the core function of nuclear speckles -splicing of GC-levelled exons- and traced the evolution of this gene architecture and condensates themselves to amniotes.
25.02.2026 16:53
π 70
π 18
π¬ 0
π 2
Redirecting
Our most recent work on the βfunction and evolutionβ of #nuclear-speckles is now online at Cell @cp-cell.bsky.social
doi.org/10.1016/j.ce...
Read the threadπ for the highlights of our findings.
25.02.2026 16:01
π 122
π 59
π¬ 9
π 5
Three @biorxivpreprint.bsky.social preprints on acute depletion of FACT in ES cells. First, from my colleague at Pitt Sarah Hainer's lab 1/ www.biorxiv.org/content/10.6...
27.02.2026 20:44
π 17
π 7
π¬ 2
π 0
Phase separation?
26.02.2026 12:07
π 3
π 0
π¬ 1
π 0
Lovely paper!
26.02.2026 11:13
π 0
π 0
π¬ 0
π 0
Bravo to our neighbours!
26.02.2026 10:09
π 9
π 1
π¬ 1
π 0
We are excited to be recruiting a new tenure track group leader in the Structural Studies Division at MRC LMB! It is an amazing place to start your own lab.
@mrclmb.bsky.social
Please get in touch if you have any questions.
www.nature.com/naturecareer...
25.02.2026 22:25
π 51
π 54
π¬ 1
π 0